Higher dose DHA supplementation during pregnancy and early preterm birth

Carlson SE, Gajewski BJ, Valentine CJ, et al.

Higher dose DHA supplementation during pregnancy and early preterm birth

19 Feb 2025

This randomised, double-blind, adaptive-design superiority trial investigated whether a higher dose of docosahexaenoic acid (DHA) supplementation during pregnancy could reduce the incidence of early preterm birth (EPB), defined as delivery before 34 weeks' gestation. Conducted across three medical centers in the United States, the study enrolled 1,100 pregnant women with singleton pregnancies between 12 and 20 weeks' gestation.

Participants were randomly assigned to receive either 1,000 mg or 200 mg of DHA daily until delivery. The results indicated a lower rate of EPB in the higher-dose group (1.7%) compared to the lower-dose group (2.4%), with a more pronounced effect observed in women who had low DHA levels at enrollment.

The study suggests that a daily intake of 1,000 mg DHA during pregnancy may reduce the risk of early preterm birth, especially in women with initially low DHA status.

Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomised, double-blind, adaptive-design superiority trial.
Carlson SE, Gajewski BJ, Valentine CJ, et al. EClinicalMedicine 2021; 36: 100905.

https://pubmed.ncbi.nlm.nih.gov/34308309/

Spread the word
DHA preterm birth Research
Back to blog